Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Large prostate links to more hair loss, but age of onset doesn't affect it.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Three white adults had a rare scalp condition with increased fat and sometimes hair loss, suggesting it's not limited to black women and might be more widespread.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

A teenage girl with high androgen levels and PCOS developed a rare liver tumor, suggesting a possible link between high androgens and the tumor's growth.

Injecting platelet-derived growth factors into ovaries may improve IVF outcomes by enhancing egg quality and embryo health.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Skin-derived stem cells can become various cell types, including germ cell-like and oocyte-like cells.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Acne is an important sign of androgen excess disorders in women.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Moderately high prolactin levels do not cause hair loss in women.